Locations
Conditions
Treatments
Institutions
Resources
For researchers
About us
Clinical trials
Phase III Study of Rilvegostomig in Combination With Bevacizumab With or Without Tremelimumab as First-line Treatment of Hepatocellular Carcinoma
Apply
Rilvegostomig, Bevacizumab, Tremelimumab, Atezolizumab
Phase III Study of Rilvegostomig in Combination With Bevacizumab With or Without Tremelimumab as First-line Treatment of Hepatocellular Carcinoma
Basic information
Step 1/5
Provide your basic information
Age
ZIP code
Back
Next step